
Financial information at 30 September 2020
Follow the Group's Financial information at 30 September 2020 - On Friday, November 13th 2020 from 9:00 am (Paris time).
Medical errors are the third most common cause of death after cardiovascular disease and cancer. To limit these risks, Biomodex offers surgeons an opportunity to practise before they operate. How? Not by practising on real patients, but on 3D prints that mimic the human anatomy. They reproduce the biomechanical properties of the body, organs and tissues, giving surgeons the impression that they are operating on their patient’s double.
"This award has given our small startup an amazing reputation boost."
Thomas Marchand - Co-founder and CEO of Biomodex
A real revolution in the medtech world, Biomodex won in the ‘e-health’ category of the 2016 EDF Pulse Awards. And that was only the beginning: following its win, the French startup raised $3.6 million in the United States in April 2016, allowing it to recruit 20 talented employees and open a subsidiary in Boston. Ultimately, the 3D prints will be used both as training equipment for surgeons and for pre-operation practice.